ArticleFrontiers in public health2025
Human papillomavirus vaccine uptake and associated factors among adolescent girls in Bona district, Sidama regional state, Ethiopia: a community-based study design.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In developing nations, adult women's cancer deaths are mostly caused by cervical cancer. Vaccination against the human papillomavirus (HPV) is one of the cost-effective global strategies for cervical cancer prevention, though vaccine uptake remains low in low-resource settings like Ethiopia. Despite the vaccine's proven effectiveness in tackling cervical-related deaths, there is a dearth of evidence in Ethiopia, particularly in the study region, regarding the HPV vaccine uptake and its influencing factors. Objective: This study aimed to determine HPV vaccination uptake and its associated factors among adolescent girls aged 14-19 years in the Bona district of Sidama regional State of Ethiopia. Methods: A community-based cross-sectional study was conducted in the Bona district, Sidama region, Ethiopia, from June 1, 2024, to July 29, 2024. A systematic random sampling method was employed to recruit 833 study participants. Data were collected using a pretested, structured interviewer-administered questionnaire. The collected data were entered into Epi Data version 4.6 and exported to SPSS version 25 software for final analysis. Binary logistic regression models were used to identify factors associated with HPV vaccine uptake. Variables with a Results: In this study, the overall prevalence of HPV vaccination uptake was 49.58% [(95% CI: 46.18-52.98)]. Urban residence [AOR = 2.84 (95% CI: 1.87-4.31)], Educational status with college and above [AOR = 1.79 (95% CI 1.23-3.67)], Overall knowledge about HPV infection vaccine and cervical cancer [AOR = 2.53 (1.82-3.51)] and positive attitude towards vaccination [AOR = 2.12 (95% CI: 1.53-2.94)] were significantly associated with HPV vaccine uptake. Conclusion: Almost one in two girls in the district took the HPV vaccine. The study implies that empowering women through education, promoting health awareness about HPV, cervical cancer, and the HPV vaccine, and implementing targeted interventions for rural populations are essential means to increase HPV vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.